|
Update on Cancer PainPain Unlocked: Evidence-Based Cancer Pain
|
Update on Cancer Pain
Practical strategies to improve comfort, function, and quality of life
This focused, 4-hour course CME course delivers real-world tools to assess and manage cancer-related pain — from identifying neuropathic and nociceptive components to choosing safer opioids, adjuvants like ketamine or buprenorphine, and knowing when to refer for interventional care. Built for busy clinicians across specialties, it’s clear, evidence-based, and ready to apply. Taught by experts. Backed by our 100% money-back guarantee.
Suitable for Primary Care/Internists, Pain Specialists, Oncologists, Oncology Nurses/Nurse Practitioners
Course Lectures
- Update on Cancer Pain
- Cancer Pain Pharmacologic Approaches
- Chemotherapy-Induced Neuropathy and Its Treatment
- Interventional Pain Therapies and Cancer
Course Benefits
- All lectures available now
- 4 AMA PRA Category 1 CME Credits™ included
- Course syllabus pdf with all slide content
- 12-month access to course recordings
Update on Cancer Pain Agenda
|
Update on Cancer Pain – David J. Copenhaver, MD, MPH
|
|
Cancer Pain Pharmacologic Approaches – David J. Copenhaver, MD, MPH
|
|
Chemotherapy-Induced Neuropathy and Its Treatment – David J. Copenhaver, MD, MPH
|
|
Interventional Pain Therapies and Cancer – David J. Copenhaver, MD, MPH
|
Q: Who should take the Update on Cancer Pain course?
A: Oncologists, palliative care clinicians, primary care physicians, anesthesiologists, pain specialists, nurse practitioners, and other clinicians who manage cancer-related pain. The course is built for busy clinicians and focuses on immediately actionable strategies.
Q: Will this change my day-to-day practice or is it mostly theoretical?
A: The course emphasizes actionable care pathways, dosing examples, and documentation tips you can use immediately, not just theory.
Q: Will this course help me reduce opioid harms while still controlling cancer pain
A: Absolutely. You’ll learn opioid-stewardship approaches, rotation strategies, and opioid-sparing adjuvants (including low-dose ketamine and partial agonists) that preserve function while minimizing adverse effects.
Q: When should I refer a patient for interventional care (intrathecal pumps, neurolytic blocks, SCS/DRG)?
A: The course provides clear referral criteria and clinical examples so you can identify appropriate candidates and time referrals to maximize benefit and minimize delays.
Q: Are interventional therapies and neuromodulation discussed?
A: Yes. Intrathecal drug delivery, neurolytic blocks, spinal cord stimulation and dorsal root ganglion stimulation are included with guidance on indications and referral timing.
Q: Will this course help me manage chemotherapy-induced peripheral neuropathy (CIPN)?
A: The CIPN module covers pathophysiology, phenotype recognition, pharmacologic options, topical/compound therapies, and neuromodulation considerations for refractory cases.
Q: What if the course doesn’t meet my needs?
A: We offer a 100% money-back guarantee — try it risk-free.
 |
David Copenhaver, MD |
Dr. David J. Copenhaver, MD, MPH, is a board certified anesthesiologist and pain medicine specialist who leads the Division of Pain Medicine at UC Davis Health. He serves as Chief of the Division of Pain Medicine, Director of Cancer Pain Management & Supportive Care, and Director of Pain Telehealth Programs, while holding clinical professorships in pain medicine and neurological surgery.
Dr. Copenhaver’s clinical practice focuses on complex pain conditions, including cancer related pain, craniofacial pain and complex regional pain syndrome. He integrates advanced techniques such as neuromodulation and intrathecal drug delivery to optimize patient outcomes. Guided by a philosophy of comprehensive cancer pain management, he aims to reduce pain, restore function and improve quality of life for his patients.
His research interests span health services administration, pain education, responsible opioid therapy management, targeted drug delivery and the application of stem cells in intervertebral disc disease. A UC Davis alumnus, Dr. Copenhaver completed his medical degree and MPH at UCLA and trained in anesthesiology at Columbia University before returning to UC Davis for fellowship training in pain medicine. He is recognized nationally as a Professor, Division Chief and Vice Chair in the Department of Anesthesiology and Pain Medicine; he founded UC Davis’s Cancer Pain and Supportive Care program and received the American Academy of Pain Medicine’s Presidential Commendation for Cancer Pain Education in 2024. Dr. Copenhaver also serves as editor of Bonica’s Pain Management and chairs the AAPM Cancer Pain Special Interest Group.
Intended Audience: Physicians
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of PeerPoint Medical Education Institute and American Physician Institute for Advanced Professional Studies, LLC. PeerPoint Medical Education Institute is accredited by the ACCME to sponsor continuing medical education for physicians.
Designation Statement:
Online Course, Release Date August 15, 2025, Termination Date August 14, 2028:
PeerPoint Medical Education Institute designates the enduring formats for this educational activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurses & Nurse Practitioners: For all your CE requirements for recertification, the ANCC will accept AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
Physician Assistants: The NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
Licensed Psychologists: Most state boards will accept AMA PRA Category 1 Credits™ toward professional development hours. Please confirm with your state board before using this product for professional development hours.
Why This Course Matters
Cancer pain is common and too often under-recognized, especially when it’s neuropathic or treatment-related. A thoughtful, stepwise approach can make a big difference: less suffering, fewer opioids, and better quality of life. This course focuses on what works in real practice, including accurate pain typing, smart use of adjuvants, when to refer, and how to partner with patients in decision-making.
What You’ll Gain from This Cancer Pain Update
This course gives you practical, evidence-backed tools to better assess and manage cancer-related pain across care settings. You’ll get a biopsychosocial framework for pain evaluation, clear guidance on mechanism-based pharmacologic strategies (including opioid rotation and adjuvants), practical approaches for managing CIPN and bone metastases, and referral-ready insights on interventional and neuromodulation options — all distilled into real-world, ready-to-use care pathways.
The content is distilled into real-world, ready-to-use care pathways designed to improve comfort, function, and quality of life while reducing unnecessary opioid exposure.
Better Advocate for Your Patients with Cancer Pain
Your patients look to you not just for treatment, but for relief, dignity, and a life they can enjoy. Investing in this training helps you become that advocate so you can stop guessing, act with confidence, and restore comfort and function faster. Learn practical ways to ease suffering, protect quality of life, and have the tough conversations that lead to better outcomes for the people who depend on you.
Update on Cancer Pain |
$149
|
Register Now |
American Physician
